Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
20.76 USD | +0.73% | -1.36% | +44.54% |
05:45pm | Kura Oncology Enrolls 85 Patients in Ziftomenib Trial for Leukemia Drug | MT |
02/05 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.54% | 157.01Cr | |
+3.99% | 11TCr | |
+11.45% | 11TCr | |
-12.69% | 2.23TCr | |
-3.70% | 2.19TCr | |
-6.03% | 1.86TCr | |
-35.21% | 1.81TCr | |
-10.26% | 1.7TCr | |
+2.96% | 1.37TCr | |
+36.80% | 1.24TCr |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Kura Oncology, Mirati Therapeutics Launch Collaboration, Supply Deal to Assess KO-2806, Adagrasib to Treat Lung Cancer